Research to be presented includes a “seven-year snapshot of the adult-use and medical-use cannabis industry in Massachusetts”
If there is one thing that the Massachusetts Cannabis Control Commission has a lot of, it is data. From extensive information on sales to tabs on active licenses across the state, one could spend a week simply getting acquainted with the agency’s various public resources. And while many are still clamoring for even more data—particularly regarding product potency and safety testing—there are already troves available to parse.
At the helm with that info is CCC Chief of Research Dr. Julie K. Johnson, who is even well respected among many critics of the state commission. That’s in part due to her work in the greater cannabis community, from publishing in journals to presenting at industry events—the next of which is coming up in a few months in Michigan. As Johnson wrote on social media last week …
“We are thrilled to be presenting three Cannabis Control Commission projects at the upcoming Research Society on Marijuana (RSMJ) Conference in July, including an applied cannabis research and policy Symposium, Ensuring Cannabis Policies aren’t Half Baked: Pairing Policy with Science, with Cannabis Regulators Association (CANNRA) colleagues, Dr. Grace Christensen, Minnesota Department of Health; Dr. Kaitlin Kosinski, New York State Office of Cannabis Management; and Dr. Lirit Franks, University of Utah School of Medicine.”
CCC research to be presented includes:
- Outlook of the Massachusetts Medical Cannabis Program Eight Years After Adult-Use Legalization and Implementation.
- Where There’s Smoke: Estimating Access to Legal Cannabis in Massachusetts through Objective and Subjective Measures.
- A seven-year snapshot of the adult-use and medical-use cannabis industry in Massachusetts— What can revenue and costs tell us about overall industry health?
